151 related articles for article (PubMed ID: 14663368)
41. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
[TBL] [Abstract][Full Text] [Related]
42. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
[TBL] [Abstract][Full Text] [Related]
43. Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma.
Doorduijn JK; Buijt I; van der Holt B; van Agthoven M; Sonneveld P; Uyl-de Groot CA
Haematologica; 2004 Sep; 89(9):1109-17. PubMed ID: 15377472
[TBL] [Abstract][Full Text] [Related]
44. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653
[TBL] [Abstract][Full Text] [Related]
45. A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation.
Olivieri A; Lucesole M; Capelli D; Gini G; Montanari M; Candela M; Troiani E; Scortechini I; Poloni A; Leoni P
Biol Blood Marrow Transplant; 2005 Aug; 11(8):627-36. PubMed ID: 16041313
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Vose JM; Link BK; Grossbard ML; Czuczman M; Grillo-Lopez A; Gilman P; Lowe A; Kunkel LA; Fisher RI
J Clin Oncol; 2001 Jan; 19(2):389-97. PubMed ID: 11208830
[TBL] [Abstract][Full Text] [Related]
47. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
Costello RT; Zerazhi H; Charbonnier A; de Colella JM; Alzieu C; Poizot-Martin I; Cohen R; Bardou VJ; Xerri L; Olive D; Nezri M; Lepeu G; Gastaut JA
Cancer; 2004 Feb; 100(4):667-76. PubMed ID: 14770420
[TBL] [Abstract][Full Text] [Related]
48. [Dose reduction is not recommended for elderly patients undergoing chemotherapy for non-Hodgkin lymphoma].
Sonneveld P; Huijgens PC; Hagenbeek A
Ned Tijdschr Geneeskd; 1999 Feb; 143(8):418-9. PubMed ID: 10221113
[TBL] [Abstract][Full Text] [Related]
49. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
[TBL] [Abstract][Full Text] [Related]
50. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
Bonnet C; Fillet G; Mounier N; Ganem G; Molina TJ; Thiéblemont C; Fermé C; Quesnel B; Martin C; Gisselbrecht C; Tilly H; Reyes F;
J Clin Oncol; 2007 Mar; 25(7):787-92. PubMed ID: 17228021
[TBL] [Abstract][Full Text] [Related]
51. [Dose-effects and chemotherapy dose intensity of aggressive non-Hodgkin's lymphomas in the adult].
Solal-Céligny P; Colombat P
Bull Cancer; 1998 Mar; 85(3):232-8. PubMed ID: 9752311
[TBL] [Abstract][Full Text] [Related]
52. Clinical trials for malignant lymphoma in Japan.
Tobinai K; Hotta T
Jpn J Clin Oncol; 2004 Jul; 34(7):369-78. PubMed ID: 15342663
[TBL] [Abstract][Full Text] [Related]
53. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
[No Abstract] [Full Text] [Related]
54. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
55. Rituximab tolerability when given before or after CHOP.
Hannawa IS; Bestul DJ
J Oncol Pharm Pract; 2011 Dec; 17(4):381-6. PubMed ID: 21109616
[TBL] [Abstract][Full Text] [Related]
56. Effects of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome.
Vaisheva F; Delbes G; Hales BF; Robaire B
J Androl; 2007; 28(4):578-87. PubMed ID: 17409468
[TBL] [Abstract][Full Text] [Related]
57. Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
Gimeno E; Sánchez-González B; Alvarez-Larrán A; Pedro C; Abella E; Comín J; Saumell S; García-Pallarols F; Gómez M; Besses C; Salar A
Leuk Res; 2011 Mar; 35(3):358-62. PubMed ID: 20708263
[TBL] [Abstract][Full Text] [Related]
58. [Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
Urasiński I; Zdziarska B; Wichert K; Zuk E
Pol Merkur Lekarski; 1998 Mar; 4(21):137-9. PubMed ID: 9640064
[TBL] [Abstract][Full Text] [Related]
59. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
60. A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma.
Swaneveld FH; van Vugt RM; de Boer JP; Dijkmans BA; Lems WF
Clin Rheumatol; 2008 Feb; 27(2):249-51. PubMed ID: 17660934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
